What does ORION PHARMA do?

ORION PHARMA is a wholesaler in Mechelen. Private Limited, started on 17 December 2009, 1 establishment.

What is the address of ORION PHARMA?

The registered office of ORION PHARMA is located at Battelsesteenweg 455 box D, 2800 Mechelen.

Is ORION PHARMA still active?

Yes. According to the CBE (31 October 2026) ORION PHARMA is active, legal situation “Normale toestand”, started on 17 December 2009.

Is ORION PHARMA registered on Peppol?

Yes, ORION PHARMA is registered on the Peppol network with ID 0208:0821527741.

What is the enterprise number of ORION PHARMA?

The enterprise number of ORION PHARMA is BE0821527741.

When was ORION PHARMA founded?

ORION PHARMA was founded on 17 December 2009.

Who are the directors of ORION PHARMA?

According to the 2025 annual accounts, the directors of ORION PHARMA are: Robert Borgdorf, Hao Pan.

Is ORION PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 December 2009; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did ORION PHARMA make in 2025?

ORION PHARMA posted a profit after taxes of € 137,817 in financial year 2025.

What is the revenue of ORION PHARMA?

In its most recent annual accounts (2025), ORION PHARMA reported revenue of € 4,437,772.

How much does an employee at ORION PHARMA earn?

The average wage cost per full-time employee at ORION PHARMA was € 122,200 in 2025: staff costs of € 2.6 million for 21.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ORION PHARMA have?

According to the 2025 annual accounts, ORION PHARMA has 21.6 full-time equivalents (FTE).

ORION PHARMA (Private Limited) - Mechelen - BE0821527741

Dossier ORION PHARMA, printed on 1 November 2026 from databakkes.be/en/0821527741/orion-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

12 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

ORION PHARMA from Mechelen, company number BE0821527741, closed financial year 2025 with a result of € 137,817 after tax. For that financial year ORION PHARMA recorded revenue of € 4.4 million and equity of € 822,015. Compared with financial year 2024, the result moved from € 133,253 to € 137,817. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 822,015

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 137,817

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 427,711

▲ 119% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 803,465.

People and assets in 2025

Full-time equivalents

21.6

▲ 13.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 1.6 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 2.6 million

▲ 82% vs 2024

€ 122,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 25,489

▼ 12% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,802

▼ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 1 days on average.

Taxes and wages

€ 388,516

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 4,460,104 Revenue 2022: € 4,460,104 First fiscal year in the series	€ 3,449,951 Revenue 2023: € 3,449,951 ▼ 23% vs 2022 (€ 4,460,104) Unfavourable step	€ 3,513,295 Revenue 2024: € 3,513,295 ▲ 2% vs 2023 (€ 3,449,951) Favourable step	€ 4,437,772 Revenue 2025: € 4,437,772 ▲ 26% vs 2024 (€ 3,513,295) Favourable step	▲ 26%
Profit after taxes	€ 60,344 Profit after taxes 2022: € 60,344 First fiscal year in the series	€ 84,050 Profit after taxes 2023: € 84,050 ▲ 39% vs 2022 (€ 60,344) Favourable step	€ 133,253 Profit after taxes 2024: € 133,253 ▲ 59% vs 2023 (€ 84,050) Favourable step	€ 137,817 Profit after taxes 2025: € 137,817 ▲ 3% vs 2024 (€ 133,253) Favourable step	▲ 3%
Equity	€ 466,895 Equity 2022: € 466,895 First fiscal year in the series	€ 550,945 Equity 2023: € 550,945 ▲ 18% vs 2022 (€ 466,895) Favourable step	€ 684,198 Equity 2024: € 684,198 ▲ 24% vs 2023 (€ 550,945) Favourable step	€ 822,015 Equity 2025: € 822,015 ▲ 20% vs 2024 (€ 684,198) Favourable step	▲ 20%
Total debts	€ 295,518 Total debts 2022: € 295,518 First fiscal year in the series	€ 533,301 Total debts 2023: € 533,301 ▲ 80% vs 2022 (€ 295,518) Unfavourable step	€ 525,869 Total debts 2024: € 525,869 ▼ 1% vs 2023 (€ 533,301) Favourable step	€ 394,318 Total debts 2025: € 394,318 ▼ 25% vs 2024 (€ 525,869) Favourable step	▼ 25%
Cash	€ 471,116 Cash 2022: € 471,116 First fiscal year in the series	€ 32,132 Cash 2023: € 32,132 ▼ 93% vs 2022 (€ 471,116) Unfavourable step	€ 195,116 Cash 2024: € 195,116 ▲ € 162,984 vs 2023 (€ 32,132) Favourable step	€ 427,711 Cash 2025: € 427,711 ▲ 119% vs 2024 (€ 195,116) Favourable step	▲ 119%
Retained profit	€ 448,345 Retained profit 2022: € 448,345 First fiscal year in the series	€ 532,395 Retained profit 2023: € 532,395 ▲ 19% vs 2022 (€ 448,345) Favourable step	€ 665,648 Retained profit 2024: € 665,648 ▲ 25% vs 2023 (€ 532,395) Favourable step	€ 803,465 Retained profit 2025: € 803,465 ▲ 21% vs 2024 (€ 665,648) Favourable step	▲ 21%
Balance sheet total	€ 762,413 Balance sheet total 2022: € 762,413 First fiscal year in the series	€ 1,084,246 Balance sheet total 2023: € 1,084,246 ▲ 42% vs 2022 (€ 762,413) Unchanged	€ 1,210,067 Balance sheet total 2024: € 1,210,067 ▲ 12% vs 2023 (€ 1,084,246) Unchanged	€ 1,216,334 Balance sheet total 2025: € 1,216,334 ▲ 1% vs 2024 (€ 1,210,067) Unchanged	▲ 1%
Employees (FTE)	6.6 Employees (FTE) 2022: 6.6 First fiscal year in the series	6.4 Employees (FTE) 2023: 6.4 ▼ 0.2 vs 2022 (6.6) Unchanged	7.7 Employees (FTE) 2024: 7.7 ▲ 1.3 vs 2023 (6.4) Unchanged	21.6 Employees (FTE) 2025: 21.6 ▲ 13.9 vs 2024 (7.7) Unchanged	▲ 13.9

Key figures of ORION PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ORION PHARMA?

What happened at ORION PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 137,817 (▲ 3% vs 2024). filed late Source: NBB ↗
Dec 17, 2009 New establishment in Mechelen. KBO
Dec 17, 2009 Start of the company according to the CBE. KBO

In short

From € 60,344 profit in 2022 to € 137,817 profit in 2025.

Paid € 228,944 in corporate taxes since 2022.

Best year ever: 2025, with € 137,817 profit.

Pays suppliers within 1 days on average.

Original PDFs at the National Bank ↗

Management

Robert Borgdorf Hao Pan

ORION PHARMA

Behind ORION PHARMA are Robert Borgdorf and Hao Pan.

Directors

According to the 2025 annual accounts

Robert Borgdorf

Director

Hao Pan

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Battelsesteenweg 455 box D

2800 Mechelen

2.184.521.459

Battelsesteenweg 455D

2800 Mechelen

Active since 17 December 2009

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.

All companies at this address →

HEALTH MANAGEMENT ASSOCIATES

€ -6,502 gross margin · 2025

Saint - Frères (Belgique)

KOOP PUTBORINGEN

€ 213,051 gross margin · 2025

I.M. Belgium

€ -40,490 gross margin · 2025

VMware Belgium

€ 11.4 million revenue · 2025

+7 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0821.527.741

VAT number

BE 0821.527.741

Registered office

Battelsesteenweg 455 bus D, 2800 Mechelen

Names & denominations

ORION PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 December 2009

Peppol

Active · Active since 6 Jan 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Markt- en opinieonderzoek

Activiteiten van reclamebureaus

View on CBE Public ↗ Annual accounts (NBB) ↗

ORION PHARMA

Warning lights

Financials

What happened to ORION PHARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions